scholarly journals An Improved Prediction Model for Ovarian Cancer Using Urinary Biomarkers and a Novel Validation Strategy

2019 ◽  
Vol 20 (19) ◽  
pp. 4938 ◽  
Author(s):  
Shin-Wha Lee ◽  
Ha-Young Lee ◽  
Hyo Joo Bang ◽  
Hye-Jeong Song ◽  
Sek Won Kong ◽  
...  

This study was designed to analyze urinary proteins associated with ovarian cancer (OC) and investigate the potential urinary biomarker panel to predict malignancy in women with pelvic masses. We analyzed 23 biomarkers in urine samples obtained from 295 patients with pelvic masses scheduled for surgery. The concentration of urinary biomarkers was quantitatively assessed by the xMAP bead-based multiplexed immunoassay. To identify the performance of each biomarker in predicting cancer over benign tumors, we used a repeated leave-group-out cross-validation strategy. The prediction models using multimarkers were evaluated to develop a urinary ovarian cancer panel. After the exclusion of 12 borderline tumors, the urinary concentration of 17 biomarkers exhibited significant differences between 158 OCs and 125 benign tumors. Human epididymis protein 4 (HE4), vascular cell adhesion molecule (VCAM), and transthyretin (TTR) were the top three biomarkers representing a higher concentration in OC. HE4 demonstrated the highest performance in all samples withOC(mean area under the receiver operating characteristic curve (AUC) 0.822, 95% CI: 0.772–0.869), whereas TTR showed the highest efficacy in early-stage OC (AUC 0.789, 95% CI: 0.714–0.856). Overall, HE4 was the most informative biomarker, followed by creatinine, carcinoembryonic antigen (CEA), neural cell adhesion molecule (NCAM), and TTR using the least absolute shrinkage and selection operator (LASSO) regression models. A multimarker panel consisting of HE4, creatinine, CEA, and TTR presented the best performance with 93.7% sensitivity (SN) at 70.6% specificity (SP) to predict OC over the benign tumor. This panel performed well regardless of disease status and demonstrated an improved performance by including menopausal status. In conclusion, the urinary biomarker panel with HE4, creatinine, CEA, and TTR provided promising efficacy in predicting OC over benign tumors in women with pelvic masses. It was also a non-invasive and easily available diagnostic tool.

2009 ◽  
Vol 69 (4) ◽  
pp. 1469-1476 ◽  
Author(s):  
Jill K. Slack-Davis ◽  
Kristen A. Atkins ◽  
Christine Harrer ◽  
E. Daniel Hershey ◽  
Mark Conaway

2017 ◽  
Vol 292 (15) ◽  
pp. 6339-6351 ◽  
Author(s):  
Petra C. Buchanan ◽  
Kristin L. M. Boylan ◽  
Bruce Walcheck ◽  
Rachel Heinze ◽  
Melissa A. Geller ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document